L2-1530-E4 Flashcards
Contained in this deck is ___________________
Content: Comfort, Mobility, Inflammation drugs, Anti-infective, Antineoplastic agents
Concepts: Comfort, Mobility, Inflammation
Chapters 24 Neurologic and Neuromuscular Agents
Chapters 25, 26 Anti-inflammatories, Analgesics
Chapters 29, 30, 31 Antibacterial and Anti-infective Agents
Chapters 32, 33, 34 Additional Anti-infective Agents
Chapters 37, 38, 39 Antineoplastic Agents
- The nurse is preparing to care for a patient who has myasthenia gravis. The nurse will be alert to symptoms affecting which body system in this patient?
a. Cardiovascular system and postural muscles
b. Central nervous system (CNS), memory, and cognition
c. Gastrointestinal system (GI) and lower extremity muscles
d. Respiratory system and facial muscles
ANS: D
d. Respiratory system and facial muscles
Myasthenia gravis causes fatigue and muscular weakness of the respiratory system, facial muscles, and extremities. It does not directly affect the cardiovascular system, CNS, or GI systems.
- A 40-year-old woman is diagnosed with myasthenia gravis, and her provider recommends removal of her thymus gland. She asks the nurse why this would be helpful. The nurse will explain that removal of the thymus gland may
a. increase binding of acetylcholine (ACh) molecules to ACh receptors.
b. increase the amount of ACh available at neuromuscular junction sites.
c. reduce the number of acetylcholine receptor sites.
d. reduce the autoimmune destruction of ACh receptor sites.
ANS: D
d. reduce the autoimmune destruction of ACh receptor sites.
Myasthenia gravis is an autoimmune disorder involving an antibody response against a subunit of the ACh receptor site. Since the thymus is involved in systemic immunity, it is thought that removing the thymus can inhibit this process. It does not increase binding of ACh molecules to receptors or increase the amount of ACh or reduce the number of ACh receptor sites.
- The nurse assumes care of a patient who has myasthenia gravis and notes that a dose of neostigmine (Prostigmin) due 1 hour prior was not given. The nurse will anticipate the patient to exhibit which symptoms?
a. Excessive salivation
b. Muscle spasms
c. Muscle weakness
d. Respiratory paralysis
ANS: C
c. Muscle weakness
Neostigmine must be given on time to prevent myasthenic crisis, which is characterized by generalized, severe muscle weakness. The other symptoms are characteristic of cholinergic crisis, caused by too much medication.
- The nurse is caring for a patient who has myasthenia gravis (MG) and takes pyridostigmine bromide (Mestinon) 60 mg every 4 hours. The patient’s last dose was 45 minutes prior. The nurse notes severe muscle weakness, excess salivation, fasciculations of facial muscles, and pupil constriction. The nurse will perform which action?
a. Assess the patient for signs of ptosis.
b. Notify the provider to discuss an order for intravenous immune globulin (IVIG).
c. Obtain an order for atropine sulfate.
d. Request an order for an extra dose of pyridostigmine.
ANS: C
c. Obtain an order for atropine sulfate.
Severe muscle weakness, excess salivation, fasciculations of facial muscles, and pupil constriction are the major signs of cholinergic crisis, caused by excess pyridostigmine. The antidote is atropine, so the nurse should obtain an order to give this. Ptosis is sign of myasthenic crisis. IVIG is given to treat symptoms of MG and not used for cholinergic crisis. Giving extra pyridostigmine would increase the symptoms.
- The nurse is caring for a patient who has myasthenia gravis (MG) and is receiving pyridostigmine bromide (Mestinon). The nurse notes ptosis of both eyelids and observes that the patient has difficulty swallowing. What action will the nurse perform next?
a. Contact the provider to request an order for atropine sulfate.
b. Contact the provider to request an order for edrophonium chloride (Tensilon).
c. Report signs of cholinergic crisis to the provider.
d. Report signs of myasthenic crisis to the provider.
ANS: B
b. Contact the provider to request an order for edrophonium chloride (Tensilon).
Overdosing and underdoing of AChE inhibitors have similar symptoms: muscle weakness, dyspnea, and dysphagia. Edrophonium may be used to diagnose MG or to distinguish between myasthenic crisis and cholinergic crisis since it is a very short-acting AChE inhibitor. When given, if the symptoms are alleviated, the cause is myasthenic crisis; if symptoms worsen, it is cholinergic crisis. Since patients can have similar symptoms, the nurse cannot report one or the other to the provider without more information.
- A patient experiences severe muscle weakness, and the provider orders edrophonium bromide (Tensilon). The patient begins to show improved muscle strength within a few minutes after administration of this drug. The nurse anticipates the provider will order which drug?
a. Atropine sulfate
b. Edrophonium bromide (Tensilon)
c. Intravenous immune globulin (IVIG)
d. Pyridostigmine HCl (Mestinon)
ANS: D
d. Pyridostigmine HCl (Mestinon)
In this case, edrophonium is used to diagnose myasthenia gravis. Since symptoms improved with the AChE inhibitor, the patient will benefit from a longer-acting AChE inhibitor such as pyridostigmine. Atropine is given for AChE inhibitor overdose. Edrophonium is very short-acting, so it will not be used for treatment. IVIG is used when other AChE inhibitors fail.
- A patient exhibits ptosis of both eyes, and the provider orders edrophonium (Tensilon). The nurse notes immediate improvement of the ptosis. The nurse understands that this patient most likely has which disorder?
a. Cerebral palsy
b. Multiple sclerosis
c. Muscle spasms
d. Myasthenia gravis
ANS: D
d. Myasthenia gravis
Improvement of symptoms after administration of edrophonium is diagnostic for myasthenia gravis.
- The charge nurse observes a nurse administer undiluted intravenous pyridostigmine bromide (Mestinon) at a rate of 0.8 mg/min. The charge nurse will stop the infusion and perform which action?
a. Administer atropine sulfate to prevent cholinergic crisis.
b. Monitor the patient closely for respiratory distress.
c. Suggest that the nurse dilute the medication with colloidal fluids.
d. Tell the nurse to slow the rate of infusion of the pyridostigmine.
ANS: D
d. Tell the nurse to slow the rate of infusion of the pyridostigmine.
When given, IV pyridostigmine should be administered undiluted at a rate of 0.5 mg/min and should not be added to IV fluids. It is not necessary to administer atropine, since the patient is not symptomatic of cholinergic crisis.
- A patient reports weakness of the extremities and diplopia. The nurse knows that these symptoms are characteristic of which condition?
a. Cerebral palsy (CP)
b. Multiple sclerosis (MS)
c. Myasthenia gravis (MG)
d. Parkinson’s disease (PD)
ANS: B
b. Multiple sclerosis (MS)
Diplopia and weakness of the extremities are two symptoms of MS. CP is characterized by muscle spasticity. MG involves generalized weakness, especially of facial muscles and respiratory muscles. PD manifests as tremors and difficulty moving and walking.
- A patient has symptoms that are characteristic of multiple sclerosis (MS). Which diagnostic tests are likely to be ordered to aid in the diagnosis of this patient?
a. Cerebrospinal fluid (CSF) immunoglobulin G and magnetic resonance imaging (MRI)
b. CSF proteins and an angiography
c. Serum albumin and a computed tomography (CT) scan
d. Serum anti-acetylcholine antibodies and x-rays
ANS: A
a. Cerebrospinal fluid (CSF) immunoglobulin G and magnetic resonance imaging (MRI)
Laboratory tests that may suggest MS include CSF IgG and MRI.
- The nurse is caring for a patient who has recurrent muscle spasms. The provider has ordered metaxalone (Skelaxin) to treat the spasms. The nurse learns that the patient has a history of drug and alcohol abuse. The nurse will contact the provider to discuss switching this patient to which medication?
a. Carisoprodol (Soma)
b. Chlorzoxazone (Parafon forte DSC)
c. Cyclobenzaprine (Flexeril)
d. Methocarbamol (Robaxin)
ANS: C
c. Cyclobenzaprine (Flexeril)
Cyclobenzaprine is a muscle relaxant that does not cause drug dependence. The other muscle relaxants can cause drug dependence.
- The nurse provides teaching to a patient who will begin taking cyclobenzaprine (Flexeril) to treat muscle spasms. Which statement by the patient indicates a need for further teaching?
a. “I may experience dizziness and drowsiness when I take this drug.”
b. “I should not consume alcohol while taking this medication.”
c. “I should take this medication with food to decrease stomach upset.”
d. “I will take this medication for three weeks and then stop taking it.”
ANS: D
d. “I will take this medication for three weeks and then stop taking it.”
This medication should not be stopped abruptly. Patients may experience dizziness and drowsiness. Alcohol will compound the central nervous system sedative effects. To decrease gastrointestinal upset, the nurse should counsel the patient to take it with food.
- The nurse is performing an admission assessment on a patient who has been taking carisoprodol (Soma) for 3 weeks to treat muscle spasms. The patient reports that the muscle spasms have resolved. The nurse will contact the provider to discuss
a. changing to cyclobenzaprine (Flexeril).
b. continuing the carisoprodol for 1 more week.
c. discontinuing the carisoprodol now.
d. ordering a taper of the carisoprodol.
ANS: D
d. ordering a taper of the carisoprodol.
Muscle relaxants can cause drug dependence and should not be withdrawn abruptly. The nurse should discuss a drug taper.
- The nurse is teaching a group of nursing students about multiple sclerosis (MS). Which statement by the nurse is correct
a. “MS is characterized by degeneration of neurons and nerves in the brain and spinal cord.”
b. “MS is characterized by lesions or plaques on myelin sheaths of nerves.”
c. “MS is characterized by neuritic plaques and neurofibrillary tangles in the CNS.”
d. “MS is characterized by weak muscles and decreased nerve impulses caused by decreased ACh.”
ANS: B
b. “MS is characterized by lesions or plaques on myelin sheaths of nerves.”
MS is characterized by lesions on myelin sheaths of nerves.
- The nurse is caring for a patient who has multiple sclerosis. The patient is experiencing an acute attack. Which drug does the nurse anticipate the provider will order?
a. Adrenocorticotropic hormone (ACTH)
b. Cyclophosphamide (Cytoxan)
c. Glatiramer acetate (Copaxone)
d. Interferon-B (IFN-B)
ANS: A
a. Adrenocorticotropic hormone (ACTH)
ACTH is given to treat an acute attack of MS. Glatiramer acetate and interferon are used for remission-exacerbation states. Cyclophosphamide is given for chronic, progressive symptoms.
- The nurse is performing a health history on a patient who has multiple sclerosis. The patient reports episodes of muscle spasticity and recurrence of muscle weakness and diplopia. The nurse will expect this patient to be taking which medication?
a. Adrenocorticotropic hormone (ACTH)
b. Cyclophosphamide (Cytoxan)
c. Cyclobenzaprine (Flexeril)
d. Interferon-B (IFN-B)
ANS: D
d. Interferon-B (IFN-B)
This patient is showing signs of remission and exacerbation of MS symptoms. Interferon is used to treat this phase. ACTH is used for acute attacks. Cyclophosphamide is used for chronic, progressive symptoms. Cyclobenzaprine is a centrally acting muscle relaxant that is used for muscle spasms to decrease pain and increase range of motion.
- The nurse is preparing to care for a patient who has multiple sclerosis (MS). The nurse learns that the patient receives cyclophosphamide (Cytoxan). The nurse knows that this patient is in which stage of MS?
a. Acute attack phase
b. Chronic, progressive phase
c. End-stage phase
d. Remission-exacerbation phase
ANS: B
b. Chronic, progressive phase
Cyclophosphamide is used to treat MS patients who are in the chronic, progressive phase.
- Which muscle relaxant is used in surgery as a skeletal muscle relaxant?
a. Baclofen (Lioresal)
b. Chlorzoxazone (Parafon forte)
c. Pancuronium bromide (Pavulon)
d. Methocarbamol (Robaxin)
ANS: C
c. Pancuronium bromide (Pavulon)
Pancuronium bromide is used as a depolarizing muscle relaxant during anesthesia.
- The nurse is preparing to administer methocarbamol (Robaxin) to a patient who is experiencing acute muscle spasms. The nurse notes that the patient’s urine has turned black. What will the nurse do?
a. Administer the next dose of methocarbamol since this is a harmless side effect.
b. Contact the provider to discuss changing to cyclobenzaprine (Flexeril).
c. Obtain an order for a complete blood count to evaluate blood loss.
d. Request an order for liver function tests since this indicates hepatotoxicity.
ANS: A
a. Administer the next dose of methocarbamol since this is a harmless side effect.
Urine may turn green, brown, or black in patients taking methocarbamol, and this is a harmless side effect. There is no need to change medications or order lab tests.
- A client with myasthenia gravis is experiencing a cholinergic crisis. Which symptoms are associated with this condition? (Select all that apply.)
a. Bradycardia
b. Rash
c. Vomiting
d. Fever
e. Drooling
f. Weakness
ANS: A, C, E, F
a. Bradycardia
c. Vomiting
e. Drooling
f. Weakness
Bradycardia, drooling, and weakness can all occur with cholinergic crisis.
- A nursing student asks the nurse to explain the role of cyclooxygenase-2 (COX-2) and its role in inflammation. The nurse will explain that COX-2
a. converts arachidonic acid into a chemical mediator for inflammation.
b. directly causes vasodilation and increased capillary permeability.
c. irritates the gastric mucosa to cause gastrointestinal upset.
d. releases prostaglandins, which cause inflammation and pain in tissues.
ANS: A
a. converts arachidonic acid into a chemical mediator for inflammation
COX-2 is an enzyme that converts arachidonic acid into prostaglandins and their products, and this synthesis causes pain and inflammation. They do not act directly to cause inflammation. COX-1 irritates the gastric mucosa. COX-2 synthesizes but does not release prostaglandins.
- A nursing student asks how nonsteroidal antiinflammatory drugs (NSAIDs) work to suppress inflammation and reduce pain. The nurse will explain that NSAIDs
a. exert direct actions to cause relaxation of smooth muscle.
b. inhibit cyclooxygenase that is necessary for prostaglandin synthesis.
c. interfere with neuronal pathways associated with prostaglandin action.
d. suppress prostaglandin activity by blocking tissue receptor sites.
ANS: B
b. inhibit cyclooxygenase that is necessary for prostaglandin synthesis.
NSAIDs act by inhibiting COX-1 and COX-2 to help block prostaglandin synthesis. They do not have direct action on tissues, nor do they interfere with chemical receptor sites or neuronal pathways.
- A patient is taking ibuprofen 400 mg every 4 hours to treat moderate arthritis pain and reports that it is less effective than before. What action will the nurse take?
a. Counsel the patient to discuss a prescription NSAID with the provider.
b. Recommend adding aspirin to increase the antiinflammatory effect.
c. Suggest asking the provider about a short course of corticosteroids.
d. Tell the patient to increase the dose to 800 mg every 4 hours.
ANS: A
a. Counsel the patient to discuss a prescription NSAID with the provider.
The patient should discuss another NSAID with the provider if tolerance has developed to the over-the-counter NSAID. Patients should not take aspirin with NSAIDs because of the increased risk of bleeding and gastrointestinal upset. Steroids are not the drugs of choice for arthritis because of their side effects and are not used unless inflammation is severe. A prescription NSAID would be used prior to starting corticosteroids. Increasing the dose will increase side effects but may not increase desired effects. The maximum dose per day is 2400 mg, which would most likely be exceeded when increasing the dose to 800 mg every 4 hours.